SkinTE is currently available for investigational use only. Submission of a biologics license application (BLA) to the U.S. Food and Drug Administration is expected in 2026, after which additional ...
BOCA RATON, Fla.--(BUSINESS WIRE)-- Sensus Healthcare, Inc. (SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for ...
Management reiterated that the CPT code revisions are expected to take effect January 1, 2027, potentially expanding the addressable market to over 30 million patients and tripling the company's total ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback